Loading…

A comparison of the effectiveness of cervical medial branch radiofrequency ablation for chronic facet joint syndrome in patients selected by two common medial branch block paradigms

Cervical medial branch radiofrequency ablation (CMBRFA) is effective when patients are selected by dual medial branch blocks (MBBs). SIS guidelines recommend 100% pain improvement after dual comparative MBBs before CMBRFA; however, our prior investigation showed similar outcomes in those selected by...

Full description

Saved in:
Bibliographic Details
Published in:Interventional Pain Medicine (Online) 2022-06, Vol.1 (2), p.100091, Article 100091
Main Authors: Burnham, Taylor R., Clements, Nathan, Conger, Aaron, Kuo, Keith, Lider, Joshua, Caragea, Marc, Kendall, Richard, Cunningham, Shellie, Meiling, James B., Teramoto, Masaru, McCormick, Zachary L.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cervical medial branch radiofrequency ablation (CMBRFA) is effective when patients are selected by dual medial branch blocks (MBBs). SIS guidelines recommend 100% pain improvement after dual comparative MBBs before CMBRFA; however, our prior investigation showed similar outcomes in those selected by a lesser strict paradigm. Compare pain and patient impression of improvement after CMBRFA in individuals stratified by a less stringent (80–99%) dual MBB response than those selected by the 100% criteria. Cross-sectional study. Follow-up was conducted via standardized telephone survey at ≥6 months post-CMBRFA to obtain Numerical Rating Scale (NRS) pain and Patient Global Impression of Change (PGIC) scores. Primary and secondary outcomes were within-group and between-group differences in the proportions of patients reporting ≥50% NRS score reduction and PGIC scores. Medical records of 195 consecutive patients were reviewed; 100 individuals were analyzed. 48% (95% CI 35–61%) and 52% (95% CI 37–67%) of the 80–99% and 100% MBB groups, reported ≥50% pain reduction at ≥6 months post-CMBRFA. 74% (95% CI 63–85%) and 67% (95% CI 52–81%) of the 80–99% and 100% MBB groups reported a PGIC score consistent with “improved” or “very much improved.” There were no significant between-group differences in any outcome at any time point. We observed similar rates of pain relief and global improvement after CMBRFA in patients selected by dual MBBs with ≥80% symptom relief versus 100% relief. This provides evidence that a more practical criteria, compared to a more strict selection paradigm, may result in similar clinical outcomes.
ISSN:2772-5944
2772-5944
DOI:10.1016/j.inpm.2022.100091